Bone marrow transplantation in patients with storage diseases: a developing country experience.

Bone marrow transplantation (BMT) is a therapeutic option for patients with genetic storage diseases. Between 1979 and 2002, eight patients, four females and four males (1 to 13 years old) were submitted to this procedure in our center. Six patients had mucopolysaccharidosis (MPS I in 3; MPS III in one and MPS VI in 2), one had adrenoleukodystrophy (ALD) and one had Gaucher disease. Five patients had related and three unrelated BMT donor. Three patients developed graft versus host disease (two MPS I and one MPS VI) and died between 37 and 151 days after transplantation. Five patients survived 4 to 16 years after transplantation. Three patients improved (one MPS I; one MPS VI and the Gaucher disease patient), one patient had no disease progression (ALD) and in one patient this procedure did not change the natural course of the disease (MPS III).

[1]  O. Barsottini,et al.  Axoval neuropathy as initial manifestation of primary amyloidosis: report of a case submitted to bone marrow transplantation. , 2004, Arquivos de neuro-psiquiatria.

[2]  H. Moser,et al.  Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. , 2004, Blood.

[3]  M. Poe,et al.  Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. , 2004, The New England journal of medicine.

[4]  C. Peters.  Effective treatment of the central nervous system in lysosomal storage diseases: save that brain! , 2003, The Journal of laboratory and clinical medicine.

[5]  E. Bayever,et al.  The status of hematopoietic stem cell transplantation in lysosomal storage disease. , 2003, Pediatric neurology.

[6]  H. Moser,et al.  Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy , 2003, Neurology.

[7]  C. Peters,et al.  Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines , 2003, Bone Marrow Transplantation.

[8]  L. Kappos,et al.  Hematopoietic stem cell transplantation for multiple sclerosis , 2002, Journal of Neurology.

[9]  A. Erikson.  Remaining problems in the management of patients with Gaucher disease , 2001, Journal of Inherited Metabolic Disease.

[10]  N. Shimozawa,et al.  Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy , 2000, Journal of Inherited Metabolic Disease.

[11]  W. Krivit,et al.  Hematopoietic cell transplantation for mucopolysaccharidosis IIB (Hunter syndrome); an ethical commentary , 2000, Bone Marrow Transplantation.

[12]  W. Krivit,et al.  Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. , 1999, Current opinion in hematology.

[13]  W. Krivit,et al.  Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. , 1999, Current opinion in neurology.

[14]  T. Masszi,et al.  Bone marrow transplantation in non-malignant disorders. , 1998, Bone marrow transplantation.

[15]  J. Wagner,et al.  Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. , 1998, Blood.

[16]  P. Kaplan,et al.  Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. , 1996, Blood.

[17]  Jerry R. Hobbs,et al.  REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATION , 1981, The Lancet.

[18]  Y. Beyth,et al.  ALPHA-FETOPROTEIN DURING MID-TRIMESTER INDUCED ABORTION , 1975, The Lancet.

[19]  W. Krivit.  Stem cell bone marrow transplantation in patients with metabolic storage diseases. , 2002, Advances in pediatrics.

[20]  K. Sullivan,et al.  Bone Marrow Transplantation for Non-Malignant Disease. , 2000, Hematology. American Society of Hematology. Education Program.